Study population:People living with HIV, sex workers, transpeople, men who have sex with men, people who use drugs or people in prisons. People who belong to more than one group listed above.
|
|
Study design:
The following designs IF they report on self-stigma as an outcome:Randomised controlled trials. Controlled clinical trials. Prospective controlled cohort studies. Retrospective controlled cohort studies if baseline exposure data were collected at time of baseline of study. Controlled before and after studies including econometric studies. Interrupted time series studies.
|
Qualitative studies. Observational studies that do not assess any intervention effects. Cross-sectional studies. Psychometric studies validating self-stigma measurements but not assessing intervention effects. Prevalence studies that do not assess intervention effects.
|
Outcome measureOne or more measures of self-stigma relating to HIV status or other infectious diseases among key populations, sex work, drug use, male-to-male intercourse, transgender identity or expression, incarceration. Multidimensional stigma outcome measure that differentiates between self-stigma and other types of stigma (ie, enacted stigma) when reporting intervention effects.
|
|